HIV related peptides

An HIV relatierte Peptide

Peptides liées au HIV

Abstract

Fragments of HIV p17 protein ranging in length from about 12 to about 40 amino acids are used to form diagnostics and vaccines for detection or treatment of AIDS. Specific peptide fragments extend from the N-terminal to the C-terminal. Peptides having the amino acid sequences shown by the following formula (I), (II), (III), (IV) and (V): are immunoreactive to antibodies in sera of patients testing seropositive for p17 of HIV-1.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (3)

    Publication numberPublication dateAssigneeTitle
    EP-0230222-A1July 29, 1987F. Hoffmann-La Roche AgExpression des HTLV-III Gag-Gens
    EP-0322394-A2June 28, 1989Smithkline Biologicals S.A.Expression des protéines de HIV dans E.coli et S.cerevisiae
    EP-0330359-A2August 30, 1989Bio-Rad Laboratories, Inc.Composition useful in the diagnosis and treating of HIV-1 infection

NO-Patent Citations (0)

    Title

Cited By (2)

    Publication numberPublication dateAssigneeTitle
    US-7541036-B2June 02, 2009Medestea Internazionale S.R.L.Human immunodeficiency virus type 1 (HIV-1) matrix (MA or p17) polypeptide capable of inducing anti-p17 antibodies that neutralize the proinflammatory activities of the MA protein
    WO-03016337-A1February 27, 2003Medestea Internazionale S.R.L.Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope